Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 1:697:59-65.
doi: 10.1016/j.neulet.2018.04.013. Epub 2018 Apr 5.

Deregulation of autophagy and vesicle trafficking in Parkinson's disease

Affiliations
Review

Deregulation of autophagy and vesicle trafficking in Parkinson's disease

Patricia Sheehan et al. Neurosci Lett. .

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease characterized pathologically by the selective loss of dopaminergic neurons in the substantia nigra and the intracellular accumulation of α-synuclein in the Lewy bodies. While the pathogenic mechanisms of PD are poorly understood, many lines of evidence point to a role of altered autophagy and membrane trafficking in the development of the disease. Emerging studies show that connections between the deregulation of autophagy and synaptic vesicle (SV) trafficking may contribute to PD. Here we review the evidence that many PD related-genes have roles in both autophagy and SV trafficking and examine how deregulation of these pathways contributes to PD pathogenesis. This review also discusses recent studies aimed at uncovering the role of PD-linked genes in autophagy-lysosome function.

Keywords: Autophagy; LRRK2; Parkinson’s disease; Synaptic trafficking.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

None.

Figures

Figure 1
Figure 1. PD linked genes have roles in SV trafficking
Synaptic vesicles release neurotransmitters through highly regulated and tightly coupled rounds of exo- and endocytosis. Many PD-linked genes including α-synuclein, LRRK2, EndoA, synj1, auxilin, syt11, and dynamin are involved in SV cycling, particularly in SV endocytosis. LRRK2 and Parkin, associated with familial PD, are known to post-translationally modify a number of SV endocytosis genes. LRRK2 phosphorylates the SV endocytosis proteins: EndoA, synj1 as well as multiple Rab GTPases that may be involved in SV cycling. Parkin ubiquitinates EndoA, synj1, syt11, and dynamin though more studies are necessary to determine how modification of these proteins influence their function in SV cycling.
Figure 2
Figure 2. Involvement of PD linked genes in SV trafficking and autophagy degradation pathways
Many genes implicated in PD have roles in multiple neuronal trafficking and degradation pathways. For example, LRRK2 and its substrate, EndoA and synj1, are implicated in the dual regulation of SV trafficking and autophagy. The Rab GTPases, also LRRK2 substrates, are likely to regulate trafficking in a number of these pathways but further study of their roles in neurons is necessary. The other PD genes shown here have been implicated in various pathways and require further study to determine their roles in these pathways and how PD-related mutations alter their function. Putative LRRK2 substrates are underlined.

Similar articles

Cited by

References

    1. Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017;32:1264–1310. - PMC - PubMed
    1. Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR International Parkinson’s Disease Genomics C, T 23andMe Research. A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet. 2017;49:1511–1516. - PMC - PubMed
    1. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A. Genome-wide genotyping in Parkinson’s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2006;5:911–916. - PubMed
    1. Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, Pant PV, Frazer KA, Cox DR, Ballinger DG. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet. 2005;77:685–693. - PMC - PubMed
    1. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet. 2009;41:1308–1312. - PMC - PubMed

Publication types